Elevated expression of HIF-1α and the loss of prolyl hydroxylase enzyme 3 (PHD3) and factor inhibiting HIF (FIH) in the nucleus have been observed in 125 BRCA-associated breast cancers [41]. This evidence concerns the gene EGLN3 and breast cancer.